Bio Key International Stock Price To Book

BKYI Stock  USD 0.92  0.04  4.55%   
BIO Key International fundamentals help investors to digest information that contributes to BIO Key's financial success or failures. It also enables traders to predict the movement of BIO Stock. The fundamental analysis module provides a way to measure BIO Key's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIO Key stock.
The BIO Key's current Price To Book Ratio is estimated to increase to 1.66.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BIO Key International Company Price To Book Analysis

BIO Key's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current BIO Key Price To Book

    
  21.62 X  
Most of BIO Key's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIO Key International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

BIO Price To Book Driver Correlations

Understanding the fundamental principles of building solid financial models for BIO Key is extremely important. It helps to project a fair market value of BIO Stock properly, considering its historical fundamentals such as Price To Book. Since BIO Key's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BIO Key's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BIO Key's interrelated accounts and indicators.
0.99-0.68-0.29-0.11-0.060.89-0.06-0.520.650.21-0.30.41-0.22-0.110.210.680.580.490.44-0.120.6-0.06-0.12
0.99-0.7-0.18-0.21-0.20.86-0.18-0.430.630.11-0.230.37-0.15-0.070.280.640.530.40.54-0.020.650.0-0.07
-0.68-0.70.230.350.2-0.860.190.19-0.08-0.340.13-0.460.01-0.090.12-0.01-0.59-0.42-0.610.15-0.890.220.41
-0.29-0.180.23-0.42-0.74-0.42-0.290.84-0.21-0.680.57-0.390.580.380.54-0.33-0.72-0.850.480.790.040.780.68
-0.11-0.210.35-0.420.63-0.090.44-0.350.310.14-0.350.03-0.42-0.42-0.340.140.20.32-0.58-0.27-0.52-0.28-0.14
-0.06-0.20.2-0.740.630.070.66-0.60.110.6-0.370.18-0.42-0.29-0.460.190.370.49-0.72-0.64-0.43-0.53-0.42
0.890.86-0.86-0.42-0.090.070.06-0.440.450.39-0.260.43-0.16-0.08-0.050.340.740.590.43-0.260.73-0.26-0.33
-0.06-0.180.19-0.290.440.660.06-0.16-0.120.52-0.06-0.06-0.090.1-0.26-0.04-0.020.26-0.37-0.43-0.230.050.12
-0.52-0.430.190.84-0.35-0.6-0.44-0.16-0.45-0.530.75-0.550.750.440.37-0.65-0.54-0.680.30.590.00.450.41
0.650.63-0.08-0.210.310.110.45-0.12-0.45-0.17-0.360.13-0.37-0.410.260.730.420.210.040.05-0.01-0.07-0.02
0.210.11-0.34-0.680.140.60.390.52-0.53-0.17-0.220.2-0.20.21-0.410.120.370.7-0.37-0.770.07-0.41-0.49
-0.3-0.230.130.57-0.35-0.37-0.26-0.060.75-0.36-0.22-0.730.990.750.69-0.3-0.2-0.240.080.18-0.010.110.1
0.410.37-0.46-0.390.030.180.43-0.06-0.550.130.2-0.73-0.66-0.67-0.530.210.30.240.320.080.45-0.13-0.18
-0.22-0.150.010.58-0.42-0.42-0.16-0.090.75-0.37-0.20.99-0.660.760.68-0.31-0.17-0.220.190.210.120.130.1
-0.11-0.07-0.090.38-0.42-0.29-0.080.10.44-0.410.210.75-0.670.760.51-0.22-0.23-0.080.04-0.210.070.210.04
0.210.280.120.54-0.34-0.46-0.05-0.260.370.26-0.410.69-0.530.680.510.39-0.11-0.220.190.3-0.010.270.25
0.680.64-0.01-0.330.140.190.34-0.04-0.650.730.12-0.30.21-0.31-0.220.390.330.4-0.14-0.15-0.09-0.1-0.05
0.580.53-0.59-0.720.20.370.74-0.02-0.540.420.37-0.20.3-0.17-0.23-0.110.330.8-0.04-0.520.37-0.81-0.79
0.490.4-0.42-0.850.320.490.590.26-0.680.210.7-0.240.24-0.22-0.08-0.220.40.8-0.26-0.740.2-0.72-0.65
0.440.54-0.610.48-0.58-0.720.43-0.370.30.04-0.370.080.320.190.040.19-0.14-0.04-0.260.560.860.450.32
-0.12-0.020.150.79-0.27-0.64-0.26-0.430.590.05-0.770.180.080.21-0.210.3-0.15-0.52-0.740.560.130.630.64
0.60.65-0.890.04-0.52-0.430.73-0.230.0-0.010.07-0.010.450.120.07-0.01-0.090.370.20.860.130.04-0.09
-0.060.00.220.78-0.28-0.53-0.260.050.45-0.07-0.410.11-0.130.130.210.27-0.1-0.81-0.720.450.630.040.91
-0.12-0.070.410.68-0.14-0.42-0.330.120.41-0.02-0.490.1-0.180.10.040.25-0.05-0.79-0.650.320.64-0.090.91
Click cells to compare fundamentals
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

BIO Book Value Per Share

Book Value Per Share

1.99

As of now, BIO Key's Book Value Per Share is increasing as compared to previous years.
Based on the latest financial disclosure, BIO Key International has a Price To Book of 21.6239 times. This is 266.51% higher than that of the Software sector and notably higher than that of the Information Technology industry. The price to book for all United States stocks is 127.38% lower than that of the firm.

BIO Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIO Key's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIO Key could also be used in its relative valuation, which is a method of valuing BIO Key by comparing valuation metrics of similar companies.
BIO Key is currently under evaluation in price to book category among its peers.

BIO Fundamentals

About BIO Key Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BIO Key International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIO Key using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO Key International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
Check out BIO Key Piotroski F Score and BIO Key Altman Z Score analysis.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.66)
Revenue Per Share
6.323
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.56)
Return On Equity
(4.58)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.